Case Study MAPPs for Vaccine Design To identify MHC class I presented antigens derived from influenza strain H1N1, two sets of human epithelial cells are cultured, one is transfected with H1N1 antigen.
More information on our antibody humanisation and deimmunisation technology, including a case study on the deimmunisation of an anti-CTLA-4 antibody. Download the technical flyer : Composite-Human-Antibodies-Technical-Flyer.pdf
Further information on Abzena’s CHO, NS0 and Sp2/0 biosimilar cell line development programmes with bespoke quality assessment tailored to individual projects. This also shows past yields and timelines.